Target intelligence / Profile preview

Mitochondrial ribosome small subunit (28S subunit)

Target
28S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The mitochondrial ribosome small subunit (28S) is a specialized ribonucleoprotein complex essential for the translation of the 13 polypeptides encoded by mitochondrial DNA (mtDNA) (Greber & Ban, 2016, Annual Review of Biochemistry). These proteins are core components of the oxidative phosphorylation (OXPHOS) machinery, making the small subunit indispensable for cellular energy production (Amunts et al., 2015, Science). Structurally, it is composed of the 12S ribosomal RNA and approximately 30 mitoribosomal proteins (MRPS) (UniProt, 2024). Due to its evolutionary descent from alphaproteobacteria, the 28S subunit shares significant structural homology with the bacterial 30S ribosome, which explains the off-target toxicity of certain antibiotics like tetracyclines and aminoglycosides (Guan et al., 2000, Human Molecular Genetics). In clinical research, this subunit is being investigated as a therapeutic target in oncology, as many cancer cells rely on upregulated mitochondrial biogenesis for survival and metastasis (Lamb et al., 2015, Oncotarget). Mutations in the genes encoding the 28S subunit components are associated with severe clinical phenotypes, including Leigh syndrome and sensorineural hearing loss (PubMed, 2022).

Other names
28S ribosomal subunitMitoribosomal small subunitSSUSmall mitoribosomal subunit12S rRNA-protein complex
02

Mechanism of action

Inhibition of mitochondrial protein synthesis by binding to the 28S subunit, which interferes with the binding of aminoacyl-tRNA to the ribosomal A-site or induces translational misreading (PubMed, 2023).

03

Biological functions

Mitochondrial protein synthesisTranslationOxidative phosphorylation regulationEnergy metabolism
04

Disease associations

Mitochondrial diseasesCancerLeigh syndromeCombined oxidative phosphorylation deficiencyAminoglycoside-induced deafness
05

Safety considerations

OtotoxicityNephrotoxicityMitochondrial toxicityMyelosuppressionLactic acidosis
06

Interacting drugs

Doxycycline

6 more in the full profile.

07

Biomarkers

MT-CO1 protein expressionMitochondrial oxygen consumption rate (OCR)MRPS gene expression levelsMitochondrial mass

Beyond the preview

Go deeper on Mitochondrial ribosome small subunit (28S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosome small subunit (28S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call